Skip to content

Evaluation of the Effect of Changyou Probiotic Flavored Yogurt on Intestinal Health

Evaluation of the Effect of Changyou Probiotic Flavored Yogurt on Intestinal Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04375475
Enrollment
198
Registered
2020-05-05
Start date
2019-02-25
Completion date
2019-04-15
Last updated
2020-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal Health

Brief summary

This was a randomized, double-blind, single-center, placebo-controlled, three-arm study. The objectives of this study were to evaluate the effect of the Bright Changyou Probiotic Flavored Yogurt on: Improving gastrointestinal health; Relieving symptoms of functional constipation or functional diarrhea; Improving gut immunity; Adjusting microbiological flora in gastrointestinal tract.

Interventions

DIETARY_SUPPLEMENTBright Changyou probiotic flavored yogurt

Oral consumption of Bright Changyou probiotic flavored yogurt 100 g at a time and twice per day for 28 days. The experimental product has similar package and taste as the comparators.

DIETARY_SUPPLEMENTBright Changyou lactobacillus flavored yogurt

Oral consumption of Bright Changyou lactobacillus flavored yogurt 100 g at a time and twice per day for 28 days.

DIETARY_SUPPLEMENTBright flavored yogurt

Oral consumption of Bright flavored yogurt 100 g at a time and twice per day for 28 days.

Sponsors

Bright Dairy & Food Co., Ltd
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
25 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Men or women aged 25-45 years old; * Functional constipation or diarrhea diagnosed by Rome III criteria; * Agree not to take any dietary supplements or dairy products other than the study products during the study period; * Agree not to take any supplements or dairy products containing prebiotics/probiotics other than the study products during the study period; * Agree not to participant in other interventional studies during the study period; * Fully understand the property, purpose, benefits and potential risk and side effect from the study; * Agree to follow all study requirements and procedures; * Signed informed consent.

Exclusion criteria

* Currently receiving treatment for gastrointestinal symptoms; * Lactose intolerance; * Having diseases or conditions that may affect intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, Hirschsprung's disease, scleroderma, or Anorexia nervosa; * Currently under diet control or in use of medicine or supplements for weight control or that might affect appetite; * Have had laxatives or other substance that will enhance digestion within two weeks before the study begins; * Have had dairy products or other food containing probiotics within 10 days before the study begins; * Currently having diarrhea; * Currently pregnant or breast-feeding, or plan to be pregnant during the study period; * Not be able to follow study procedures according to investigators evaluation.

Design outcomes

Primary

MeasureTime frameDescription
Gastrointestinal health scoreDay 0, 28Change of the total gastrointestinal health score at day 28 from baseline. The total score is the sum of the 4 aspects of gastrointestinal health (each with score range from 0 to 3): Weekly stool frequency (\>=6; 4-6; 1-3; 0); Ratio of the number of unopened defecation to the total number of defecation (1; 1/4; 1/3; \>=1/2); Duration of defecation (\<5 minutes; 5-15 minutes; 16-30 minutes; \>=30 minutes); Defecation condition (normal perception; straining/uncomfortableness at stool; obvious straining/uncomfortableness or difficulty at defecation with little feces amount; frequent abdominal or anus pain that affect defecation).

Secondary

MeasureTime frameDescription
Bristol score of stool characteristicsDay 0, 3, 7, 14, 21, 281. Separate hard lumps, like nuts; 2. Sausage-shaped but lumpy; 3. Like a sausage but with cracks on the surface; 4. Like a sausage or snake, smooth and soft; 5. Soft blobs with clear-cut edges; 6. Fluffy pieces with ragged edges, a mushy stool; 7. Watery, no solid pieces, entirely liquid.
Bristol score of stool colorDay 0, 3, 7, 14, 21, 28Score from 1 to 7 for stool color from light to dark
Symptom score of digestive systemDay 0, 3, 7, 14, 21, 28Total score of the 9 aspects of digestive symptoms (each with score range from 0 to 3 indication no symptom, light symptom, moderate symptom and severe symptom): Bloating, abdominal pain, gastric distention, heavy stomach, loss of appetite, belching, intestinal colic, and abdominal colic.
Defecation satisfaction scoreDay 0, 3, 7, 14, 21, 28Total score of the satisfaction on 4 aspects of defecation habit (each with score range from 0 to 3): Stool frequency, defecation duration, stool characteristics, and defecation habit (very satisfied; satisfied; neither satisfied nor dissatisfied; dissatisfied)
Fecal short chain fatty acidsDay 0, 14Percentage of acetic acid, propionic acid and butyric acid
Fecal secretory immunoglobulin A (sIgA)Day 0, 14Fecal concentration of sIgA
Fecal bacteriumDay 0, 14Quantitative measurements of clostridium perfringens bacteria, lactobacillus, bifidobacterium and Escherichia coli.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026